Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe SARS-CoV2 Pneumonia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05870839
What this trial is testing

Study of VXCO-100, a SARS-CoV Candidate Vaccine in Healthy Adults in the United States

Who this might be right for
SARS-CoVSARS-CoV-2
Vaccine Company, Inc. 121
Large-scale testing (Phase 3)UnknownNCT04641481
What this trial is testing

An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Who this might be right for
Covid19SARS-CoV Infection
Bharat Biotech International Limited 25,800
Testing effectiveness (Phase 2)UnknownNCT04622865
What this trial is testing

Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19

Who this might be right for
SARS-CoV 2COVID-19Coronavirus Disease 2019
AB Science 200
Early research (Phase 1)Study completedNCT04646044
What this trial is testing

A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19

Who this might be right for
Covid-19Coronavirus Disease 2019
Nektar Therapeutics 30
Not applicableStudy completedNCT04745611
What this trial is testing

Neurological and Neuropsychological Sequelae of COVID-19 Infection

Who this might be right for
COVID-19 Infection
Maastricht University 329
Large-scale testing (Phase 3)Ended earlyNCT04516811
What this trial is testing

Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19

Who this might be right for
COVID-19SARS-CoV-2 InfectionSevere Acute Respiratory Syndrome Coronavirus 2
South African National Blood Service 102
Large-scale testing (Phase 3)Ended earlyNCT04928430
What this trial is testing

Efficacy and Safety of XAV-19 for the Treatment of Moderate-to-severe COVID-19

Who this might be right for
COVID-19
Xenothera SAS 290
Early research (Phase 1)Ended earlyNCT04652765
What this trial is testing

Camostat With Bicalutamide for COVID-19

Who this might be right for
Covid19SARS-CoV InfectionCoronavirus Infection
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 6
Large-scale testing (Phase 3)Ended earlyNCT04952519
What this trial is testing

Efficacy of Amantadine Treatment in COVID-19 Patients

Who this might be right for
Patients With Moderate or Severe COVID-19
Noblewell 193
Large-scale testing (Phase 3)Study completedNCT04380519
What this trial is testing

Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)

Who this might be right for
COVID-19
R-Pharm International, LLC 372
Early research (Phase 1)Study completedNCT05844202
What this trial is testing

Safety, Tolerability and Immunogenicity of Alveavax-v1.2, a BA.2/Omicron-optimized, DNA Vaccine for COVID-19 Prevention

Who this might be right for
Sars-CoV-2 Infection
Alvea Holdings, LLC 130
Not applicableStudy completedNCT05104411
What this trial is testing

Rehabilitation in Severely Ill Inpatients With COVID-19

Who this might be right for
COVID-19
Seoul National University Bundang Hospital 37
Testing effectiveness (Phase 2)Study completedNCT04761822
What this trial is testing

COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations

Who this might be right for
SARS-CoV InfectionCOVID-19Allergic Reaction+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 746
Not applicableEnded earlyNCT04569851
What this trial is testing

Clinical Characteristics and Prognostic Factors of Patients With COVID-19 (Coronavirus Disease 2019)

Who this might be right for
COVID-19 Infection
Savana Research 100,000
Large-scale testing (Phase 3)Study completedNCT04678739
What this trial is testing

Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial

Who this might be right for
Covid19Covid-19 ARDS
M Abdur Rahim Medical College and Hospital 205
Early research (Phase 1)Study completedNCT05525910
What this trial is testing

Relative Bioavailability Study of Nirmatrelvir/Ritonavir 4 Different Fixed Dose Combination Tablets Relative to the Commercial Tablets in Healthy Participants

Who this might be right for
Biological AvailabilityHealthy Participants
Pfizer 15
Early research (Phase 1)Study completedNCT04644120
What this trial is testing

Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19)

Who this might be right for
CoronaVirus Disease-2019 (COVID-19)
AbbVie 25
Not applicableStudy completedNCT04937582
What this trial is testing

Cognitive and Psychological Disorders After Severe COVID-19 Infection

Who this might be right for
COVID 19
Central Hospital, Nancy, France 76
Not applicableStudy completedNCT04330261
What this trial is testing

Clinical Characteristics and Outcomes of Pediatric COVID-19

Who this might be right for
COVID-19SARS-CoV-2 InfectionPediatric ALL+2 more
University of Calgary 10,610
Testing effectiveness (Phase 2)Ended earlyNCT04322773
What this trial is testing

Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure

Who this might be right for
Corona Virus Disease
Marius Henriksen 20
Next Page